NZ210867A - Tumour-specific monoclonal antibodies, production thereof and use - Google Patents
Tumour-specific monoclonal antibodies, production thereof and useInfo
- Publication number
- NZ210867A NZ210867A NZ210867A NZ21086785A NZ210867A NZ 210867 A NZ210867 A NZ 210867A NZ 210867 A NZ210867 A NZ 210867A NZ 21086785 A NZ21086785 A NZ 21086785A NZ 210867 A NZ210867 A NZ 210867A
- Authority
- NZ
- New Zealand
- Prior art keywords
- monoclonal antibodies
- tumour
- production
- specific monoclonal
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
This invention relates to monoclonal antibodies produced by hybridoma or transformed B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers. This invention also relates to diagnostic procedures and therapeutic approaches using these monoclonal antibodies.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57553384A | 1984-01-31 | 1984-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ210867A true NZ210867A (en) | 1989-01-06 |
Family
ID=24300700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ210867A NZ210867A (en) | 1984-01-31 | 1985-01-17 | Tumour-specific monoclonal antibodies, production thereof and use |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0151030B1 (en) |
JP (2) | JPH0759518B2 (en) |
AT (1) | ATE71410T1 (en) |
AU (2) | AU589351B2 (en) |
CA (1) | CA1340781C (en) |
DE (1) | DE3585093D1 (en) |
DK (1) | DK171896B1 (en) |
ES (1) | ES8802621A1 (en) |
GR (1) | GR850179B (en) |
HU (1) | HU209519B (en) |
IE (1) | IE58859B1 (en) |
IL (1) | IL74156A (en) |
NZ (1) | NZ210867A (en) |
PT (1) | PT79894B (en) |
ZA (1) | ZA85689B (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3319751A1 (en) * | 1983-05-31 | 1984-12-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | METHOD FOR OBTAINING TUMORANT-TREATED MONOCLONAL ANTIBODIES AND MEDICINAL PRODUCTS CONTAINING THEM |
DE3629640A1 (en) * | 1986-08-30 | 1988-03-03 | Behringwerke Ag | USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF TUMORS |
US6294172B1 (en) | 1983-08-12 | 2001-09-25 | Dade Behring Marburg Gmbh | Monoclonal antibodies with specificity for membrane-associated antigens |
US5011684A (en) * | 1985-09-05 | 1991-04-30 | Beth Israel Hospital Association | Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance |
JPS6283898A (en) * | 1985-10-09 | 1987-04-17 | Kyowa Hakko Kogyo Co Ltd | Antihuman pulmonary adenocarcinoma specific monoclonal antibody |
US5552291A (en) * | 1985-10-09 | 1996-09-03 | Kyowa, Hakko Kogyo Co., Ltd. | Anti-human pulmonary adenocarcinoma specific monoclonal antibody |
EP0222360A3 (en) * | 1985-11-12 | 1989-03-15 | Biotherapeutics Inc. | A method of producing a patient-specific cytotoxic reagent and composition |
JPS62207298A (en) * | 1986-03-06 | 1987-09-11 | Kyowa Hakko Kogyo Co Ltd | Anti-human gastric carcinoma monoclonal antibody |
JPH06100843B2 (en) * | 1986-06-23 | 1994-12-12 | キヤノン株式会社 | Insulating magnetic dry developer |
EP0265156A3 (en) * | 1986-10-14 | 1990-08-29 | Bunge (Australia) Proprietary Limited | Monoclonal antibodies |
DK169987D0 (en) * | 1987-04-03 | 1987-04-03 | Jens Christian Jensenius | HUMAN TUMOR-ASSOCIATED ANTIGEN, CA-OU1 |
HU213222B (en) * | 1987-07-02 | 1997-03-28 | Akzo Nv | Method for producing of tumor antigen recognized by monoclonal antibody, antibody directed against antigen anp antibody specific to antiidiotypic antigen |
US5215913A (en) | 1987-11-30 | 1993-06-01 | Roger Williams General Hospital | IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use |
DE3909799A1 (en) | 1989-03-24 | 1990-09-27 | Behringwerke Ag | MONOCLONAL ANTIBODIES (MAK) AGAINST TUMOR ASSOCIATED ANTIGENS, THEIR PRODUCTION AND USE |
AU629367B2 (en) * | 1989-06-19 | 1992-10-01 | Akzo N.V. | Radioimmunotherapy using alpha-particles emission |
EP0537168B1 (en) * | 1990-04-12 | 1996-05-15 | Akzo Nobel N.V. | Ctaa 28a32, the antigen recognized by mca 28a32 |
WO1992000763A1 (en) * | 1990-07-03 | 1992-01-23 | Akzo N.V. | Immunoreactive compound |
US5281710A (en) * | 1990-08-01 | 1994-01-25 | The Scripps Research Institute | Dynemicin analogs: synthesis, methods of preparation and use |
JPH06508028A (en) * | 1991-05-16 | 1994-09-14 | アクゾ・エヌ・ヴエー | Tumor-associated monoclonal antibody 81AV78 |
IL103758A (en) * | 1991-12-13 | 1998-07-15 | Akzo Nv | Tumor specific monoclonal antibodies |
JPH06113831A (en) * | 1992-04-08 | 1994-04-26 | Dev Center For Biotechnol | Hybridoma and its antibody |
EP0650735A3 (en) * | 1993-07-09 | 1999-04-14 | Akzo Nobel N.V. | Kit and method for pretargeting |
JP2006507214A (en) | 2002-02-22 | 2006-03-02 | イントラセル・リソーシーズ・エル・エル・シー | Sterile, immunogenic, non-tumorigenic tumor cell compositions and methods |
US7176022B2 (en) | 2002-12-20 | 2007-02-13 | Cell Genesys, Inc. | Directly injectable formulations which provide enhanced cryoprotection of cell products |
CN106133521A (en) * | 2013-10-02 | 2016-11-16 | 苏瑞科技有限公司 | For treating the specific immunotherapy of the sufferer of heterogeneous tumor |
EP3409297A1 (en) | 2017-05-30 | 2018-12-05 | AlfaRim Medial Holding B.V. | The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy |
WO2019057598A1 (en) | 2017-09-20 | 2019-03-28 | Alfarim Medical Holding B.V. | The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4322879A (en) * | 1978-01-11 | 1979-07-19 | Massachusetts General Hospital, The | Producing antibodies |
DE3211356A1 (en) * | 1982-03-27 | 1983-09-29 | Behringwerke Ag, 3550 Marburg | CELL HYBRID, METHOD FOR PRODUCING IT AND ITS USE |
JPS58201994A (en) * | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | Method for producing antigen-specific human immunoglobulin |
JPS59137497A (en) * | 1983-01-20 | 1984-08-07 | ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア | Antigen idiosyncratic immunogloblin producing human/human hybridoma and producing antibody |
US4613576A (en) * | 1983-03-09 | 1986-09-23 | Sloan-Kettering Institute For Cancer Research | Human monoclonal antibodies to cancer cells |
-
1985
- 1985-01-17 NZ NZ210867A patent/NZ210867A/en unknown
- 1985-01-22 GR GR850179A patent/GR850179B/el unknown
- 1985-01-23 AU AU37992/85A patent/AU589351B2/en not_active Ceased
- 1985-01-25 IE IE19285A patent/IE58859B1/en not_active IP Right Cessation
- 1985-01-25 IL IL74156A patent/IL74156A/en not_active IP Right Cessation
- 1985-01-28 PT PT79894A patent/PT79894B/en not_active IP Right Cessation
- 1985-01-29 ZA ZA85689A patent/ZA85689B/en unknown
- 1985-01-30 EP EP85300610A patent/EP0151030B1/en not_active Expired - Lifetime
- 1985-01-30 DE DE8585300610T patent/DE3585093D1/en not_active Expired - Lifetime
- 1985-01-30 AT AT85300610T patent/ATE71410T1/en not_active IP Right Cessation
- 1985-01-30 HU HU85344A patent/HU209519B/en not_active IP Right Cessation
- 1985-01-30 ES ES539987A patent/ES8802621A1/en not_active Expired
- 1985-01-30 DK DK040885A patent/DK171896B1/en not_active IP Right Cessation
- 1985-01-30 CA CA000473130A patent/CA1340781C/en not_active Expired - Lifetime
- 1985-01-31 JP JP60017692A patent/JPH0759518B2/en not_active Expired - Lifetime
-
1989
- 1989-12-29 AU AU47367/89A patent/AU635511B2/en not_active Ceased
-
1993
- 1993-10-27 JP JP5269230A patent/JP2516731B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU3799285A (en) | 1985-08-08 |
HU209519B (en) | 1994-06-28 |
JPS60260597A (en) | 1985-12-23 |
EP0151030A3 (en) | 1987-11-25 |
GR850179B (en) | 1985-05-23 |
DE3585093D1 (en) | 1992-02-20 |
EP0151030A2 (en) | 1985-08-07 |
ATE71410T1 (en) | 1992-01-15 |
IL74156A0 (en) | 1985-04-30 |
DK40885D0 (en) | 1985-01-30 |
JP2516731B2 (en) | 1996-07-24 |
EP0151030B1 (en) | 1992-01-08 |
DK171896B1 (en) | 1997-08-04 |
JPH06315395A (en) | 1994-11-15 |
IE850192L (en) | 1985-07-31 |
AU589351B2 (en) | 1989-10-12 |
IL74156A (en) | 1990-08-31 |
CA1340781C (en) | 1999-10-12 |
DK40885A (en) | 1985-10-25 |
AU4736789A (en) | 1990-05-03 |
PT79894B (en) | 1986-10-23 |
ES8802621A1 (en) | 1988-09-16 |
ES539987A0 (en) | 1988-09-16 |
AU635511B2 (en) | 1993-03-25 |
IE58859B1 (en) | 1993-11-17 |
PT79894A (en) | 1985-02-01 |
JPH0759518B2 (en) | 1995-06-28 |
HUT36859A (en) | 1985-10-28 |
ZA85689B (en) | 1986-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ210867A (en) | Tumour-specific monoclonal antibodies, production thereof and use | |
ZA833686B (en) | Human human hybridomas for cervical carcinoma | |
GR3036375T3 (en) | Monoclonal and chimeric antibodies specific for human tumor necrosis factor. | |
DK0586002T3 (en) | Monoclonal antibodies that recognize the epidermal growth factor receptor, its cells and methods, and preparations thereof | |
MX9705349A (en) | Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma. | |
ATE71225T1 (en) | USE OF A SPECIFIC TUMOR-ASSOCIATED ANTIGEN, SIALOSYLLACTOTETRAOSE, IN DIAGNOSIS OR THERAPY PROCEDURES FOR CANCER DISEASES. | |
EP0232871A3 (en) | Human monoclonal antibody, hybridoma producing the same and its use | |
EP0328578A4 (en) | Antigen recognized by mca 16-88. | |
EP0537168A4 (en) | Ctaa 28a32, the antigen recognized by mca 28a32 | |
FI935038A0 (en) | Tumoer associerad monoclonal antichrog 81AV78 | |
NO924803L (en) | TUMOR-RELATED MONOCLONAL ANTIBODY 88BV59 | |
HUT48677A (en) | Process for producing mouse hybridoma lym-2 and diagnostic antibody therefrom |